COVID-19 | Kendall Square

Disrupting the Inequalities of Covid-19 in Work and Health Care

Join us for this inaugural event in the MIT Forefront series, which will scout the frontiers of science and technology for bold new answers to urgent global problems. From health...

3:00 AM 7:00 AM – 4:00 AM
8:00 AM

Kendall on the Frontline: Vaccine Development and Rollout

Zoom into the global epicenter of innovation on Friday, January 22 at noon to get answers to your critical questions about COVID-19 vaccines and how Kendall Square’s science is leading...

7:00 AM 12:00 PM – 8:00 AM
1:00 PM

COVID-19

COVID-19 Research at Whitehead Institute

Demonstrating the multifaceted value and broad applicability of fundamental biomedical research, Whitehead Fellows Silvia Rouskin and Kipp Weiskopf have leveraged their long-term research programs — and the specialized methods and...

11:00 AM 4:00 PM – 12:00 PM
5:00 PM

COVID-19 Vaccine Information in Haitian Creole

Nou envite ou nan yon sesyon enfòmasyon konsènan vaksen COVID-19 yo. Nou gen on ekip panelis pou pale sou kesyon moun genyen souvan konsènan vaksen yo, tankou sekirite ak efikasite lejann yo, epi yo...

1:00 PM 5:00 PM – 2:00 PM
6:00 PM

Are COVID Vaccines Safe for Children? Webinar

Get answers to your important questions virtually. Wednesday, January 19 at 7:00 PM Dr. Traci Brooks, CHA Interim Chief of Pediatrics, and Dr. Lou Ann Bruno-Murtha, CHA Chief of Infectious...

2:00 PM 7:00 PM – 3:00 PM
8:00 PM

Broad Institute partners with CDC and Theiagen Genomics to enable pathogen genomic surveillance across the United States

Workers are going back to the office, just not how they expected to

COVID-19

Moderna says its vaccine prevented 100 percent of COVID-19 cases in study of adolescents 12 to 17

Here's How 13 Mass. Companies are Planning to Go Back to the Office

COVID-19

Employers can soon book appointments at mass vaccination sites — or host pop-up clinics in their offices

COVID-19

What to know about the state’s new preregistration system, which went live Friday morning

The new mRNA vaccines from Pfizer and Moderna to fight the coronavirus are based on a technology that could transform the future of medicine.

COVID-19

Last week, the Broad Genomics team processed its 10 millionth COVID-19 test! Approximately 1 in every 20 tests performed in the US daily are processed at the Broad Institute.

Community leaders are expressing major concerns about the racial disparity in the COVID-19 vaccine rollout.

COVID-19

Last week, the Gillette Stadium became a large-scale COVID-19 vaccination clinic run by CIC Health. They will aim to vaccinate 500 people a day with the Moderna vaccine and hope to double that total each successive week.

COVID-19

Pfizer's leading COVID-19 vaccine got authorized for emergency use in the United States and is out for distribution this week.

COVID-19

Moderna is asking federal regulators to authorize emergency use of its experimental COVID-19 vaccine.

COVID-19

After announcing its experimental COVID-19 vaccine to be 95% effective, Pfizer asked the FDA to authorize their COVID-19 vaccine.

COVID-19

How Kendall Champions Culture in a Global Pandemic

Workplace culture attracts, retains, and inspires talent. While every organization’s culture is unique, we all have experienced challenges related to workplace culture, especially in the transition from on-site to remote...

COVID-19

The Boston Globe's Shirley Leung and Tim Logan detail Massachusetts' options for exploring a second lockdown and the implications this can have on our economy.

COVID-19

Pfizer is getting close to having a COVID-19 vaccine ready for the public but the drug maker, the government, and the public health community faces a new challenge: quickly making millions of doses of the vaccine.

COVID-19

Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective

COVID-19

Pfizer announced that the early analysis of its trial COVID-19 vaccine was more than 90% effective in preventing the disease among volunteers.

COVID-19

Moderna's CEO has announced that their COVID-19 vaccine might be available as early as December for emergency use.

COVID-19

CIC Health is offering COVID-19 testing to organizations and individuals in an accessible, easy, and fast way.

Moderna has been working with local communities to reach a diverse population for its COVE Phase 3 study. They've now enrolled 28,618 participants in the study and approximately 34.5% of them are from diverse communities.

COVID-19

If Pfizer's COVID-19 vaccine study shows positive results by the end of the month they would have data on its safety by the third week of November.

COVID-19

Researchers at MIT and Broad Institute have been working on a CRISPR-based diagnostic that can produce COVID-19 test results in 30 minutes to an hour.

COVID-19

Pfizer's CEO, Albert Bourla said there's a chance that a COVID-19 vaccine could be distributed to the American public by the end of this October.

COVID-19

The Power of Proximity Persists — even through a Pandemic

In March, organizations all over the country scrambled to adapt their businesses as the global pandemic made its way into the U.S. As a world leader in innovation, Kendall has...

COVID-19

Since March, Broad Institute's Genomics team has processed over 1.2 million COVID-19 tests for nursing homes, hospitals, and higher education.

COVID-19

MIT is entering their next phase of campus reopening and are making sure they ramp up their testing simultaneously.

COVID-19

Moderna has found that its experimental COVID-19 vaccine shows promising results for older adults who are at higher risk of hospitalization and death.

The Future of Working with Limited Childcare

Covid-19 has created many challenges but the biggest question on every organization’s mind right now is: How do we support caregivers and create a culture that normalizes the need to...

COVID-19

Today, Moderna's COVID-19 vaccine will be entering its most important phase of testing.

This 30,000-person trial will detect several different signs of efficacy.

COVID-19

There are 11 coronavirus vaccines to keep our eye on these days, including Moderna, Pfizer, Johnson & Johnson, Sanofi, and more.

COVID-19

Novartis responding to COVID-19

Paul Aliu, Global Head of Medical Governance at Novartis, has his team working on identifying existing treatments for COVID-19 patients in the short term as others look for a vaccine. Read...

Several Kendall eateries re-open their patios this week

Phase two of the state’s reopening plan — which includes outdoor table service at restaurants — will begin on Monday, June 8. See the full list via Eater Boston.

COVID-19

Bristol Myers Squibb offers free access to all branded medicine to patients who have lost health insurance due to COVID-19

To help patients that have recently lost their health insurance due to COVID-19, Bristol Myers Squibb has expanded their patient support programs by offering access to all branded BMS medicine for free.

COVID-19

Biogen Foundation donates $10 million to provide immediate relief for communities affected by COVID-19

The Biogen Foundation is donating $10 million to provide immediate relief for communities affected by COVID-19. The funding will be used to address immediate critical needs, with the majority of donations going to support non-profit organizations that are working to address critical issues like expanding testing options, easing the strain on our medical systems, providing training and protection for front line health workers and ensuring people have access to necessities like food.

COVID-19

Enabling the Future Together

Kendall is leading in creating solutions to our current crisis and reimagining a future that is more resilient and inclusive. Together we are enabling a reimagined future in the face...